RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 312 participants.

Also called NCT01132456

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 312 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01132456
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01132456. Non-randomized; no masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2013-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia
Acronym
R-A
Condition
Ischemic Heart Disease
Condition
Coronary Stenosis
Condition
Cardiovascular Diseases
Condition
Arteriosclerosis
Intervention (Device)
Drug eluting stent treatment
Lead sponsor
Medtronic Vascular (class: industry)

Record details

Record id
cardio:ct-nct01132456
Content hash
782f45837d48ed0cdac4110ad28d9e7dd6249887e3be55dbdd4dd1a3a6e7a5ba